EP2934688A2 - Verwendung von probiotischen mikroorganismen als mittel zur förderung der synthese von melanin - Google Patents

Verwendung von probiotischen mikroorganismen als mittel zur förderung der synthese von melanin

Info

Publication number
EP2934688A2
EP2934688A2 EP13814519.8A EP13814519A EP2934688A2 EP 2934688 A2 EP2934688 A2 EP 2934688A2 EP 13814519 A EP13814519 A EP 13814519A EP 2934688 A2 EP2934688 A2 EP 2934688A2
Authority
EP
European Patent Office
Prior art keywords
cncm
longum
bifidobacterium longum
hair
subsp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP13814519.8A
Other languages
English (en)
French (fr)
Inventor
Lionel Breton
Audrey Gueniche
Michela ZUCCOLO
Annick Mercenier
Guénolé PRIOULT
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
LOreal SA
Original Assignee
Nestec SA
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA, LOreal SA filed Critical Nestec SA
Publication of EP2934688A2 publication Critical patent/EP2934688A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/04—Preparations for care of the skin for chemically tanning the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/10—Preparations for permanently dyeing the hair
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/92—Oral administration

Definitions

  • Thermal inactivation can also be performed by autoclaving by subjecting the probiotic microorganisms Bifidobacterium longum subsp. longum CNCM 1-2618 of the invention at a temperature of 121 ° C for at least 20 minutes and at an atmospheric pressure of 2 bar.
  • 2618 may be used in whole form, that is to say substantially in its native form, or in the form of extracts or lysates comprising fractions and / or metabolites of this microorganism .
  • lipophilic gelling agents mention may be made of modified clays such as bentones, metal salts of fatty acids such as aluminum stearates and hydrophobic silica, or else ethylcellulose and polyethylene.
  • the cosmetic composition used in the context of the invention may also be used to prevent and / or cosmetically treat a cutaneous and / or capillary pigmentation defect resulting from an imbalance in melanocyte homeostasis.
  • Canitia is a natural hair whitening that occurs with age, and is primarily associated with a decrease in melanin in the hair shaft. More specifically, canities are linked to a specific and progressive rarefaction of hair melanocytes, affecting both the hair bulb melanocytes and the melanocyte precursor cells.
  • the implementation of the invention makes it possible to reduce or even to slow down or delay the appearance of the white hair and the graying of the hair.
  • the present invention makes it possible to stimulate, or even reactivate, melanogenesis, in order to delay, reduce or even reduce canities.
  • the administration of the cosmetic composition according to the invention is in the form of a dietary supplement.
  • the ingredients are mixed before being shaped in the order and under conditions easily determined by those skilled in the art.
  • the inventors have thus shown that the incubation of NHEK / NHEM co-cultures with lysates of probiotic microorganisms made it possible to significantly increase melanin production by melanocytes compared with untreated cocultures (see FIG. .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
EP13814519.8A 2012-12-21 2013-12-18 Verwendung von probiotischen mikroorganismen als mittel zur förderung der synthese von melanin Withdrawn EP2934688A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1262700A FR2999932B1 (fr) 2012-12-21 2012-12-21 Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
PCT/EP2013/077212 WO2014096083A2 (fr) 2012-12-21 2013-12-18 Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine

Publications (1)

Publication Number Publication Date
EP2934688A2 true EP2934688A2 (de) 2015-10-28

Family

ID=48741231

Family Applications (1)

Application Number Title Priority Date Filing Date
EP13814519.8A Withdrawn EP2934688A2 (de) 2012-12-21 2013-12-18 Verwendung von probiotischen mikroorganismen als mittel zur förderung der synthese von melanin

Country Status (5)

Country Link
US (1) US20150297506A1 (de)
EP (1) EP2934688A2 (de)
BR (1) BR112015014846A2 (de)
FR (2) FR2999932B1 (de)
WO (1) WO2014096083A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2657665B1 (es) * 2016-09-05 2018-12-17 Pedro Jose DE LA FUENTE BLASCO Productos para la salud con probióticos inactivados y uso de dichos productos
CN112410241A (zh) * 2019-08-22 2021-02-26 丰华生物科技股份有限公司 用以抗氧化的含乳酸菌菌株或其发酵物的组合物及其用途
GB202115797D0 (en) * 2021-11-03 2021-12-15 Iiaa Ltd Compositions comprising probiotic and postbiotic strains of bacteria

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR625782A (fr) 1926-12-07 1927-08-19 Images lumineuses à transformation
DE3024318A1 (de) 1980-06-27 1982-01-28 Chemisches Laboratorium Dr. Karl Richter GmbH, 1000 Berlin Kosmetische mittel
US5352440A (en) 1988-03-30 1994-10-04 Trustees Of Boston University Methods for increasing melanin content in melanocytes using diacylglycerols and uses thereof
FR2654935B1 (fr) 1989-11-28 1994-07-01 Lvmh Rech Utilisation de xanthines, eventuellement incorporees dans des liposomes, pour favoriser la pigmentation de la peau ou des cheveux.
FR2684300B1 (fr) 1991-11-29 1994-03-11 Lvmh Recherche Composition cosmetique ou pharmaceutique, notamment dermatologique, destinee en particulier a favoriser la pigmentation de la peau ou des cheveux, contenant un extrait de ballote, et son procede de fabrication.
GB9217444D0 (en) 1992-08-17 1992-09-30 Unilever Plc Compounds compositions and methods for producing pigmentation in hair or skin
EP1160322A3 (de) 1992-08-21 2002-01-02 Wa Pharm AB Menschliche, Melanozyten stimulierende Hormonrezeptoren
US5470577A (en) 1993-07-07 1995-11-28 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
SE9303444D0 (sv) 1993-10-20 1993-10-20 Kabi Pharmacia Ab New use of prostaglandins
WO1995017161A1 (en) 1993-12-21 1995-06-29 The Board Of Regents Of The University Of Oklahoma Pigmentation enhancer and method
FR2756181B1 (fr) 1996-11-26 1999-03-05 Au Mont Beaute Composition cosmetique, pharmaceutique a base de culture inactivee de bacteries bifidobacterium, d'huile de menthe et d'un acide
EP1110555A1 (de) 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Anti-adhäsives Agens für die pathogene Hautflora
US7547527B2 (en) 2000-10-06 2009-06-16 Markus Baur Use of probiotic lactic acid bacteria for balancing the skin's immune system
ATE350010T1 (de) 2001-02-23 2007-01-15 Richter Chem Lab Zusammensetzung zur topischen anwendung
FR2834718B1 (fr) 2002-01-15 2004-12-24 Cognis France Sa Substances actives cosmetiques et/ou pharmaceutiques
US20060269508A1 (en) * 2005-03-29 2006-11-30 Trejo Amy V Means for regulating the cosmetic appearance and/or health of human keratinous tissue
KR20070067549A (ko) 2005-12-23 2007-06-28 주식회사 두산 미강 유산균 발효물을 함유하는 피부 보호 및 개선용조성물
WO2008015343A2 (fr) 2006-08-03 2008-02-07 Societe D'extraction Des Principes Actifs Sa (Vincience) Utilisation d'un extrait de levure en tant qu'agent actif pour augmenter la synthese de melanine dans les melanocytes
FR2912917B1 (fr) 2007-02-26 2012-05-18 Oreal Milieu conditionne et ses utilisations
FR2916977A1 (fr) * 2007-06-06 2008-12-12 Engelhard Lyon Sa STIMULATION DE LA SYNTHESE DES RECPTEURS MCR1, MCR2 ET µ OPIOIDE.
FR2920307B1 (fr) 2007-09-04 2010-06-04 Oreal Utilisation cosmetique de microorganismes.
FR2920306B1 (fr) * 2007-09-04 2010-07-30 Oreal Utilisation cosmetique d'un lysat de bifidobacterieum species.
FR2920300B1 (fr) 2007-09-04 2012-12-28 Oreal Utilisation d'une association hesperidine et microorganisme pour agir sur la fonction barriere de la peau.
EP2138186A1 (de) * 2008-06-24 2009-12-30 Nestec S.A. Probiotika, sekretorische IgA und Entzündung
MX336030B (es) * 2009-05-11 2016-01-07 Nestec Sa Lactobacillus johnsonii la1 mcc533 (cncm i-1225) y padecimientos inmunes.
EP2397145A1 (de) * 2010-06-18 2011-12-21 Nestec S.A. L. johnsonii La1, B. longum NCC2705 und Immunerkrankungen

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
None *
See also references of WO2014096083A2 *

Also Published As

Publication number Publication date
BR112015014846A2 (pt) 2017-07-11
US20150297506A1 (en) 2015-10-22
WO2014096083A2 (fr) 2014-06-26
FR2999932B1 (fr) 2020-01-31
FR2999932A1 (fr) 2014-06-27
FR3050110A1 (fr) 2017-10-20
WO2014096083A3 (fr) 2014-11-13

Similar Documents

Publication Publication Date Title
EP2332520B1 (de) Lactobacillus paracasei zur Behandlung von Altersflecken und / oder melasma
EP2033628B1 (de) Kosmetischer Einsatz eines Lysats einer Bifidobakteriengattung zur Behandlung von Trockenheit der Haut
EP2082731B1 (de) Verwendung einer Hesperidinverbindung und eines Mikroorganismus zur Beeinflussung der Barrierefunktion der Haut
EP2181703B1 (de) Verwendung eines Mikroorganismen-lysats zur Behandlung von fettiger Haut
EP2033627B2 (de) Einsatz eines Lysats einer Bifidobakteriengattung zur Behandlung von sensiblen Hauttypen
EP2285343B1 (de) Verwendung eines wolfsbeerenextraktes zur bewahrung und/oder wiederherstellung von straffer haut
FR2938437A1 (fr) Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
EP2332521A1 (de) Probiotische Mikroorganismen als Aktivsubstanzen gegen Veränderungen der Hautmikrostruktur
WO2009141544A2 (fr) Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques
FR2920307A1 (fr) Utilisation cosmetique de microorganismes.
FR2919501A1 (fr) Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
EP1731137A1 (de) Kosmetische oder dermatologische Zusammensetzung gegen trockene und/oder empfindliche Haut
FR3050110A1 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2930155A1 (fr) Utilisation d'un extrait de baie, et plus particulierement de wolfberry, a titre d'agent anti-pollution
FR2942720A1 (fr) Utilisation cosmetique d'hesperidine.
FR2982150A1 (fr) Acide gras mono-insature pour le soin des ongles
FR2920301A1 (fr) Utilisation d'une association hesperidine et microogansime pour le traitement de la secheresse des matieres keratiniques.
FR3047178A1 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
FR2920300A1 (fr) Utilisation d'une association hesperidine et microorganisme pour agir sur la fonction barriere de la peau.
FR3050111A1 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthese de melanine
WO2014096084A2 (fr) Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine
FR2980360A1 (fr) Utilisation cosmetique de l'hesperidine ou de l'un de ses derives dans la prevention et/ou le traitement des odeurs corporelles.
FR2967064A1 (fr) Utilisation d'extrait de grenade pour prevenir et/ou traiter les jambes lourdes

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20150618

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20170131

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20190416